Literature DB >> 22143445

[Hypoxia is a key factor in the inflammatory milieu of rheumatic diseases].

M Hahne1, T Gaber, F Buttgereit.   

Abstract

Chronic inflammatory diseases are characterized by hypoxia and subsequent cellular adaptation via hypoxia-inducible factor (HIF). Modulation of these adaptation mechanisms provides the basis for ideas on how to improve the effects of known drugs and for the development of novel therapeutic approaches.

Entities:  

Mesh：

Year:  2012        PMID： 22143445     DOI： 10.1007/s00393-011-0782-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  9 in total

Review 1.  Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors.

Authors:  Michail Sitkovsky; Dmitriy Lukashev
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

Review 2.  Hypoxia regulates macrophage functions in inflammation.

Authors:  Craig Murdoch; Munitta Muthana; Claire E Lewis
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

Review 3.  Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions.

Authors:  Thomas Hellwig-Bürgel; Daniel P Stiehl; Anika E Wagner; Eric Metzen; Wolfgang Jelkmann
Journal:  J Interferon Cytokine Res       Date:  2005-06       Impact factor: 2.607

Review 4.  Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!

Authors:  T Gaber; R Dziurla; R Tripmacher; G R Burmester; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2005-03-30       Impact factor: 19.103

5.  Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia.

Authors:  Timo Gaber; Saskia Schellmann; Kerem B Erekul; Monique Fangradt; Karolina Tykwinska; Martin Hahne; Patrick Maschmeyer; Markus Wagegg; Cindy Stahn; Paula Kolar; René Dziurla; Max Löhning; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

6.  Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Authors:  Eric V Dang; Joseph Barbi; Huang-Yu Yang; Dilini Jinasena; Hong Yu; Ying Zheng; Zachary Bordman; Juan Fu; Young Kim; Hung-Rong Yen; Weibo Luo; Karen Zeller; Larissa Shimoda; Suzanne L Topalian; Gregg L Semenza; Chi V Dang; Drew M Pardoll; Fan Pan
Journal:  Cell       Date:  2011-08-25       Impact factor: 41.582

Review 7.  Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia.

Authors:  Michail V Sitkovsky; Jorgen Kjaergaard; Dmitriy Lukashev; Akio Ohta
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates.

Authors:  Ellen M Moran; René Heydrich; Chin Teck Ng; Tajvur P Saber; Jennifer McCormick; Joachim Sieper; Heiner Appel; Ursula Fearon; Douglas J Veale
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

9.  Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts.

Authors:  David R Mole; Christine Blancher; Richard R Copley; Patrick J Pollard; Jonathan M Gleadle; Jiannis Ragoussis; Peter J Ratcliffe
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.